1/30/2009

A U.S. study involving 21 people with relapsing-remitting multiple sclerosis -- an earlier phase in the disease -- reported that about 81% showed improvement after their immune systems were reset through an injection of stem cells derived from their own bone marrow. Called autologous nonmyeloablative hematopoietic stem cell transplantation, the treatment is less toxic than the chemotherapy treatment used in cancer patients because it targets only the immune system component of bone marrow, one of the scientists said.

Full Story:
Yahoo!

Related Summaries